EE9600191A - Püridüülbisfosfonaatide kasutamine terapeutiliste toimeainetena - Google Patents

Püridüülbisfosfonaatide kasutamine terapeutiliste toimeainetena

Info

Publication number
EE9600191A
EE9600191A EE9600191A EE9600191A EE9600191A EE 9600191 A EE9600191 A EE 9600191A EE 9600191 A EE9600191 A EE 9600191A EE 9600191 A EE9600191 A EE 9600191A EE 9600191 A EE9600191 A EE 9600191A
Authority
EE
Estonia
Prior art keywords
bisphosphonates
pyridyl
therapeutic agents
bone diseases
pyridinylaminomethylidene
Prior art date
Application number
EE9600191A
Other languages
English (en)
Other versions
EE03475B1 (et
Inventor
Heikkil�-Hoikka Marjaana
Nikander Hannu
Hannuniemi Ritva
Laur�n Leena
Kleimola Terttu
Liukko-Sipi Sirpi
V��nanen Kalervo
Sellman Raija
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of EE9600191A publication Critical patent/EE9600191A/et
Publication of EE03475B1 publication Critical patent/EE03475B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EE9600191A 1994-06-09 1995-06-02 Püridinüülbisfosfonaatide kasutamine terapeutiliste toimeainetena EE03475B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9402001A SE9402001D0 (sv) 1994-06-09 1994-06-09 Pyridylbisphosphonates for use as a therapeutical agent
PCT/FI1995/000315 WO1995033466A1 (en) 1994-06-09 1995-06-02 Pyridylbisphosphonates for use as a therapeutical agent

Publications (2)

Publication Number Publication Date
EE9600191A true EE9600191A (et) 1997-06-16
EE03475B1 EE03475B1 (et) 2001-08-15

Family

ID=20394303

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9600191A EE03475B1 (et) 1994-06-09 1995-06-02 Püridinüülbisfosfonaatide kasutamine terapeutiliste toimeainetena

Country Status (27)

Country Link
US (2) US5866556A (et)
EP (1) EP0762883B1 (et)
JP (1) JP3883137B2 (et)
KR (1) KR100363692B1 (et)
CN (1) CN1077792C (et)
AT (1) ATE208622T1 (et)
AU (1) AU691616B2 (et)
BG (1) BG63104B1 (et)
BR (1) BR9508185A (et)
CZ (1) CZ291477B6 (et)
DE (1) DE69523914T2 (et)
DK (1) DK0762883T3 (et)
EE (1) EE03475B1 (et)
ES (1) ES2162919T3 (et)
HK (1) HK1012572A1 (et)
HU (1) HU228618B1 (et)
IS (1) IS1801B (et)
NO (1) NO311069B1 (et)
NZ (1) NZ287094A (et)
PL (1) PL180705B1 (et)
PT (1) PT762883E (et)
RO (1) RO119433B1 (et)
RU (1) RU2154482C2 (et)
SE (1) SE9402001D0 (et)
SK (1) SK282650B6 (et)
UA (1) UA43918C2 (et)
WO (1) WO1995033466A1 (et)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0010808A (pt) * 1999-05-21 2002-08-27 Novartis Ag Composições farmacêuticas e usos
US6420384B2 (en) 1999-12-17 2002-07-16 Ariad Pharmaceuticals, Inc. Proton pump inhibitors
JP2003531111A (ja) 1999-12-17 2003-10-21 アライアッド・ファーマシューティカルズ・インコーポレーテッド プロトンポンプインヒビター
IL150059A0 (en) * 1999-12-17 2002-12-01 Ariad Pharma Inc Novel heterocycles
ATE353656T1 (de) * 2000-10-27 2007-03-15 Schering Ag Bisphosphonsäurederivate zur stärkung von kortikalknochen
EP1482897A2 (en) * 2002-02-19 2004-12-08 Ilex Products, Inc. Aminodiphosphonate apolipoprotein e modulators
TW200413381A (en) * 2002-11-04 2004-08-01 Hoffmann La Roche Novel amino-substituted dihydropyrimido [4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents
US20050010305A1 (en) * 2003-01-28 2005-01-13 Lee Francis Y. Novel bone graft composite
US20050065171A1 (en) * 2003-06-25 2005-03-24 Shakespeare William C. Substituted purine derivatives
JP2005060303A (ja) * 2003-08-12 2005-03-10 Sutaagen:Kk 不動性骨粗鬆の治療または予防剤
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US447256A (en) * 1891-02-24 Apparatus for flashing and exhausting incandescent electric lamps
US4447256A (en) * 1977-07-20 1984-05-08 Nissan Chemical Industries, Ltd. N-(Unsubstituted or substituted pyridyl)aminomethylene-diphosphonic acids, herbicidal compositions containing same, their use for herbicides, and process for preparing same
IL77243A (en) * 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
US4973576A (en) * 1987-03-10 1990-11-27 Yamanouchi Pharmaceutical Co., Ltd. Bisphophonic acid derivatives and pharmaceutical compositions containing the same
KR880011136A (ko) * 1987-03-11 1988-10-26 모리오까 시게오 아졸- 아미노메틸렌 비스포스폰산 유도체

Also Published As

Publication number Publication date
NZ287094A (en) 1998-04-27
BR9508185A (pt) 1997-08-12
CN1077792C (zh) 2002-01-16
PL317612A1 (en) 1997-04-14
KR970703152A (ko) 1997-07-03
CN1149830A (zh) 1997-05-14
CZ356196A3 (en) 1997-07-16
WO1995033466A1 (en) 1995-12-14
DE69523914D1 (en) 2001-12-20
RO119433B1 (ro) 2004-11-30
SK157296A3 (en) 1997-06-04
RU2154482C2 (ru) 2000-08-20
EP0762883A1 (en) 1997-03-19
IS1801B (is) 2002-01-22
PT762883E (pt) 2002-05-31
AU2569895A (en) 1996-01-04
BG101116A (en) 1998-03-31
HK1012572A1 (en) 1999-08-06
SE9402001D0 (sv) 1994-06-09
US6083938A (en) 2000-07-04
SK282650B6 (sk) 2002-10-08
NO311069B1 (no) 2001-10-08
HU9603375D0 (en) 1997-01-28
DE69523914T2 (de) 2002-06-27
ES2162919T3 (es) 2002-01-16
ATE208622T1 (de) 2001-11-15
UA43918C2 (uk) 2002-01-15
CZ291477B6 (cs) 2003-03-12
BG63104B1 (bg) 2001-04-30
EP0762883B1 (en) 2001-11-14
IS4392A (is) 1996-12-02
AU691616B2 (en) 1998-05-21
NO965228L (no) 1996-12-06
EE03475B1 (et) 2001-08-15
DK0762883T3 (da) 2002-03-11
US5866556A (en) 1999-02-02
HU228618B1 (en) 2013-04-29
JP3883137B2 (ja) 2007-02-21
NO965228D0 (no) 1996-12-06
PL180705B1 (pl) 2001-03-30
JPH10500977A (ja) 1998-01-27
HUT75525A (en) 1997-05-28
KR100363692B1 (ko) 2003-02-07

Similar Documents

Publication Publication Date Title
DE69331326D1 (de) Prostaglandin-analoga zur behandlung von osteoporose
DE69736441D1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
DE69218624D1 (de) Behandlung von peridontalkrankheiten mit alendronat
SE8704248D0 (sv) Medical use
EP0786995A4 (et)
ATE232874T1 (de) Prostaglandin-konjugate zur behandlung von knochenkrankheiten
EE9600191A (et) Püridüülbisfosfonaatide kasutamine terapeutiliste toimeainetena
ATE252897T1 (de) Verwendung von p-aminophenolderivaten zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von neurodegenerativen erkrankungen
ATE238986T1 (de) 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analoga
DE69501359D1 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
ATE217191T1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
SE8903529D0 (sv) Medical use
ATE330604T1 (de) Behandlung von manischen erkrankungen
MX9606180A (es) Piridilbisfosfonatos para utilizarse como un agente terapeutico.
CA2192456A1 (en) Pyridylbisphosphonates for use as a therapeutical agent
ATE147978T1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
FR2613621B1 (fr) Butyl hydroxyanisoles pour utilisation dans le traitement prophylactique des maladies a retro-virus comme agents modificateurs de l'infectivite des retro-virus et produits anti-infectants
AU7436098A (en) Use of mizolastine for preparing a medicine for treating inflammation

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231